Giulia De Bernardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giulia De Bernardi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Laura Bianchessi
Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell’Università 6, 26900 Lodi, Italy
1 shared publication - Lauretta Turin
Department of Veterinary Medicine and Animal Sciences—DIVAS, Università degli Studi di Milano, 26900 Lodi, Italy
1 shared publication - Martina Vigorelli
Department of Veterinary Medicine and Animal Sciences—DIVAS, Università degli Studi di Milano, 26900 Lodi, Italy
1 shared publication - Paola Dall’ara
Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell’Università 6, 26900 Lodi, Italy
1 shared publication
Latest Publications
- Open Access
- 23 March 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (4) , 294
Bacteriophage Therapy in Companion and Farm Animals
Bacteriophages, which are viruses with restricted tropism for bacteria, have been employed for over a century as antimicrobial agents; they have been largely abandoned in Western countries but are constantly used in Eastern European countries with the advent of antibiotics. In recent decades, the growing spread of multidrug-resistant bacteria, which pose a serious threat to worldwide public health, imposed an urgent demand for alternative therapeutic approaches to antibiotics in animal and human fields. Based on this requirement, numerous studies have been published on developing and testing bacteriophage-based therapy. Overall, the literature largely supports the potential of this perspective but also highlights the need for additional research as the current standards are inadequate to receive approval from regulatory authorities. This review aims to update and critically revise the current knowledge on the application of bacteriophages to treat bacterial-derived infectious diseases in animals in order to provide topical perspectives and innovative advances.
- 23 March 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (4) , 294
Open AccessBacteriophage Therapy in Companion and Farm Animals
Bacteriophages, which are viruses with restricted tropism for bacteria, have been employed for over a century as antimicrobial agents; they have been largely abandoned in Western countries but are constantly used in Eastern European countries with the advent of antibiotics. In recent decades, the growing spread of multidrug-resistant bacteria, which pose a serious threat to worldwide public health, imposed an urgent demand for alternative therapeutic approaches to antibiotics in animal and human fields. Based on this requirement, numerous studies have been published on developing and testing bacteriophage-based therapy. Overall, the literature largely supports the potential of this perspective but also highlights the need for additional research as the current standards are inadequate to receive approval from regulatory authorities. This review aims to update and critically revise the current knowledge on the application of bacteriophages to treat bacterial-derived infectious diseases in animals in order to provide topical perspectives and innovative advances.